Avity Investment Management Inc. Acquires New Shares in Aflac Incorporated (NYSE:AFL)

Avity Investment Management Inc. acquired a new stake in Aflac Incorporated (NYSE:AFLFree Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 5,200 shares of the financial services provider’s stock, valued at approximately $429,000.

Several other hedge funds have also recently bought and sold shares of AFL. Panagora Asset Management Inc. increased its position in Aflac by 36.2% during the first quarter. Panagora Asset Management Inc. now owns 23,941 shares of the financial services provider’s stock worth $1,542,000 after buying an additional 6,369 shares in the last quarter. Blair William & Co. IL boosted its holdings in Aflac by 6.8% in the first quarter. Blair William & Co. IL now owns 17,268 shares of the financial services provider’s stock valued at $1,112,000 after acquiring an additional 1,102 shares during the last quarter. Aviva PLC boosted its holdings in Aflac by 0.7% in the first quarter. Aviva PLC now owns 210,634 shares of the financial services provider’s stock valued at $13,563,000 after acquiring an additional 1,503 shares during the last quarter. Dakota Wealth Management acquired a new position in Aflac in the first quarter valued at $428,000. Finally, Sequoia Financial Advisors LLC boosted its holdings in Aflac by 7.3% in the first quarter. Sequoia Financial Advisors LLC now owns 6,142 shares of the financial services provider’s stock valued at $396,000 after acquiring an additional 417 shares during the last quarter. 66.75% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AFL. StockNews.com cut Aflac from a “hold” rating to a “sell” rating in a research note on Thursday, March 14th. Morgan Stanley reduced their price objective on Aflac from $85.00 to $80.00 and set an “equal weight” rating on the stock in a research note on Friday, March 1st. Raymond James lifted their target price on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. The Goldman Sachs Group lifted their target price on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Finally, Wells Fargo & Company lifted their target price on Aflac from $82.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $80.36.

Check Out Our Latest Research Report on AFL

Insider Buying and Selling at Aflac

In other Aflac news, SVP Albert Riggieri sold 8,000 shares of the company’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the transaction, the senior vice president now owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the completion of the sale, the director now owns 5,592 shares in the company, valued at $445,850.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Albert Riggieri sold 8,000 shares of the stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 41,493 shares of company stock valued at $3,342,606. Corporate insiders own 0.90% of the company’s stock.

Aflac Stock Performance

Shares of NYSE AFL traded up $0.64 during midday trading on Wednesday, hitting $84.98. 2,133,928 shares of the company’s stock were exchanged, compared to its average volume of 2,318,386. The firm has a market cap of $49.03 billion, a P/E ratio of 10.97, a PEG ratio of 2.31 and a beta of 0.91. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. Aflac Incorporated has a twelve month low of $61.30 and a twelve month high of $86.20. The stock’s 50 day moving average price is $81.45 and its 200-day moving average price is $80.38.

Aflac (NYSE:AFLGet Free Report) last released its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The firm had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter last year, the company earned $1.29 earnings per share. Equities research analysts anticipate that Aflac Incorporated will post 6.43 EPS for the current year.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.